Protein Concentration of Refractory Ascites in Cancer Patients is Reflected by the Presence and Severity of Peritoneal and Liver Metastasis
Author:
Affiliation:
1. Department of Nephrology; Shinshu University School of Medicine; Matsumoto, Nagano Japan
Publisher
Wiley
Subject
Nephrology,Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/1744-9987.12560/fullpdf
Reference12 articles.
1. Single center experience of cell-free and concentrated ascites reinfusion therapy in malignancy related ascites;Ito;Ther Apher Dial,2014
2. Safety of repeated cell-free and concentrated ascites reinfusion therapy for malignant ascites from gastrointestinal cancer;Maeda;Mol Clin Oncol,2014
3. Novel cell-free and concentrated ascites reinfusion therapy (KM-CART) for refractory ascites associated with cancerous peritonitis: its effect and future perspectives;Matsusaki;Int J Clin Oncol,2011
4. Cell-Free and Concentrated Ascites Reinfusion Therapy for Decompensated Liver Cirrhosis;Kozaki;Ther Apher Dial,2016
5. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis;Ginès;Gastroenterology,1996
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Novel and highly reliable leak check tests for drop‐ and external pressure‐type cell‐free and concentrated ascites reinfusion therapy;Therapeutic Apheresis and Dialysis;2023-08-18
2. Mitigation of Sarcopenia after Peritoneovenous Shunt Placement in Patients with Refractory Ascites;Journal of Vascular and Interventional Radiology;2023-04
3. Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience;BMC Cancer;2022-03-14
4. Safety and efficacy of cell‐free and concentrated ascites reinfusion therapy against cirrhotic ascites in comparison with malignancy‐related ascites;Journal of Gastroenterology and Hepatology;2021-08-22
5. Evaluation of the performance, operability, and safety of Plasauto μ, a new type of machine for cell‐free and concentrated ascites reinfusion therapy, in a postmarketing clinical study;Therapeutic Apheresis and Dialysis;2021-05-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3